Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
Goy, A., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Nasta, S., O'Connor, O. A., Shi, H., Boral, A. L., Fisher, R. I.
Published in Annals of oncology (01.03.2009)
Published in Annals of oncology (01.03.2009)
Get full text
Journal Article
FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma
Li, Y, Bouchlaka, M N, Wolff, J, Grindle, K M, Lu, L, Qian, S, Zhong, X, Pflum, N, Jobin, P, Kahl, B S, Eickhoff, J C, Wuerzberger-Davis, S M, Miyamoto, S, Thomas, C J, Yang, D T, Capitini, C M, Rui, L
Published in Oncogene (01.12.2016)
Published in Oncogene (01.12.2016)
Get full text
Journal Article
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience
Hong, F., Habermann, T.M., Gordon, L.I., Hochster, H., Gascoyne, R.D., Morrison, V.A., Fisher, R.I., Bartlett, N.L., Stiff, P.J., Cheson, B.D., Crump, M., Horning, S.J., Kahl, B.S.
Published in Annals of oncology (01.03.2014)
Published in Annals of oncology (01.03.2014)
Get full text
Journal Article
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network
Kahl, BS, Longo, WL, Eickhoff, JC, Zehnder, J, Jones, C, Blank, J, McFarland, T, Bottner, W, Rezazedeh, H, Werndli, J, Bailey, HH
Published in Annals of oncology (01.09.2006)
Published in Annals of oncology (01.09.2006)
Get full text
Journal Article
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Kuo, P-Y, Leshchenko, V V, Fazzari, M J, Perumal, D, Gellen, T, He, T, Iqbal, J, Baumgartner-Wennerholm, S, Nygren, L, Zhang, F, Zhang, W, Suh, K S, Goy, A, Yang, D T, Chan, W-C, Kahl, B S, Verma, A K, Gascoyne, R D, Kimby, E, Sander, B, Ye, B H, Melnick, A M, Parekh, S
Published in Oncogene (05.03.2015)
Published in Oncogene (05.03.2015)
Get full text
Journal Article
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
VISCO, C, LI, Y, D'AMORE, Esg, MONTES-MORENO, S, DYBKAER, K, CHIU, A, TAM, W, ORAZI, A, ZU, Y, BHAGAT, G, WINTER, J. N, WANG, H.-Y, XU-MONETTE, Z. Y, O'NEILL, S, DUNPHY, C. H, HSI, E. D, ZHAO, X. F, GO, R. S, CHOI, Wwl, ZHOU, F, CZADER, M, TONG, J, ZHAO, X, MIRANDA, R. N, KRIEKEN, Jh Van, HUANG, Q, AI, W, ETZELL, J, PONZONI, M, FERRERI, Ajm, PIRIS, M. A, MØLLER, M. B, BUESO-RAMOS, C. E, MEDEIROS, U, GREEN, T. M, WU, L, YOUNG, K. H, LI, Y, TZANKOV, A, WEN, W, LIU, W-M, KAHL, B. S
Published in Leukemia (01.09.2012)
Published in Leukemia (01.09.2012)
Get full text
Journal Article
Zanubrutinib safety/tolerability profile and comparison with ibrutinib profile in B‐cell malignancies: Post hoc analysis of a large clinical trial safety database
Brown, J. R., Eichorst, B., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Cohen, A., Zhang, M., Salmi, T., Paik, J., Wang, L., Zhang, J., Ma, H., Tedeschi, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Caimi, P. F, Ai, W. Z, Alderuccio, J. P., Ardeshna, K. M, Hamadani, M., Hess, B., Kahl, B. S, Radford, J., Solh, M., Stathis, A., Zinzani, P. L., Wang, Y., Qin, Y., Wang, L., Xu, C., Carlo‐Stella, C.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY
Shadman, M., Munir, T., Roback, T., Brown, J. R., Kahl, B. S., Ghia, P., Giannopoulos, K., Šimkovič, M., Österborg, A., Laurenti, L., Walker, P., Opat, S., Ciepluch, H., Greil, R., Hanna, M., Tani, M., Trněný, M., Brander, D., Flinn, I. W., Grosicki, S., Verner, E., Tedeschi, A., De Guibert, S., Tumyan, G., Laribi, K., García, J. A., Li, J., Tian, T., Ramakrishnan, V., Liu, Y., Szeto, A., Paik, J., Cohen, A., Tam, C. S., Jurczak, W.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study
Chang, JE, Voorhees, PM, Kolesar, JM, Ahuja, HG, Sanchez, FA, Rodriguez, GA, Kim, K, Werndli, J, Bailey, HH, Kahl, BS
Published in Hematological oncology (01.03.2009)
Published in Hematological oncology (01.03.2009)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated Porphyrin
ROSENTHAL, Mark A, KAVAR, Bhadu, KAHL, Stephen B, KAYE, Andrew H, HILL, John S, MORGAN, Denis J, NATION, Roger L, STYLLI, Stanley S, BASSER, Russell L, UREN, Shannon, GELDARD, Howard, GREEN, Michael D
Published in Journal of clinical oncology (15.01.2001)
Published in Journal of clinical oncology (15.01.2001)
Get full text
Journal Article
LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Zinzani, P. L., Caimi, P. F., Carlo‐Stella, C., Ai, W., Alderuccio, J. P., Ardeshna, K. M., Hess, B., Kahl, B. S., Radford, J., Solh, M., Stathis, A., Feingold, J., Ungar, D., Qin, Y., He, S., Hamadani, M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa
MCCOY, A. G, SMITH, E. P, ATKINSON, M. E, BARANSKI, B, KAHL, B. S, JUCKETT, M, MITCHELL, T, GANGNON, R, LONGO, W. L
Published in Bone marrow transplantation (Basingstoke) (01.01.2004)
Published in Bone marrow transplantation (Basingstoke) (01.01.2004)
Get full text
Journal Article
Selective Tumor Uptake of a Boronated Porphyrin in an Animal Model of Cerebral Glioma
Hill, John S., Kahl, Stephen B., Kaye, Andrew H., Stylli, Stanley S., Koo, Myoung-Seo, Gonzales, Michael F., Vardaxis, Nicholas J., Johnson, Christopher I.
Published in Proceedings of the National Academy of Sciences - PNAS (01.03.1992)
Published in Proceedings of the National Academy of Sciences - PNAS (01.03.1992)
Get full text
Journal Article
A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model
Ceberg, C P, Brun, A, Kahl, S B, Koo, M S, Persson, B R, Salford, L G
Published in Journal of neurosurgery (01.07.1995)
Published in Journal of neurosurgery (01.07.1995)
Get more information
Journal Article
Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels
Callahan, Daniel E, Forte, Trudy M, Javed Afzal, S.M, Deen, Dennis F, Kahl, Stephen B, Bjornstad, Kathleen A, Bauer, William F, Blakely, Eleanor A
Published in International journal of radiation oncology, biology, physics (01.10.1999)
Published in International journal of radiation oncology, biology, physics (01.10.1999)
Get full text
Journal Article
Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP
Viaggi, M, Dagrosa, M.A, Longhino, J, Blaumann, H, Calzetta, O, Kahl, S.B, Juvenal, G.J, Pisarev, M.A
Published in Applied radiation and isotopes (01.11.2004)
Published in Applied radiation and isotopes (01.11.2004)
Get full text
Journal Article
In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides
Fairchild, R G, Kahl, S B, Laster, B H, Kalef-Ezra, J, Popenoe, E A
Published in Cancer research (Chicago, Ill.) (15.08.1990)
Get full text
Published in Cancer research (Chicago, Ill.) (15.08.1990)
Journal Article
Uptake of a Nido-Carboranylporphyrin by Human Glioma Xenografts in Athymic Nude Mice and by Syngeneic Ovarian Carcinomas in Immunocompetent Mice
Kahl, S. B., Joel, D. D., Nawrocky, M. M., Micca, P. L., Tran, K. P., Finkel, G. C., Slatkin, D. N.
Published in Proceedings of the National Academy of Sciences - PNAS (01.09.1990)
Published in Proceedings of the National Academy of Sciences - PNAS (01.09.1990)
Get full text
Journal Article